Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions for reducing aβ 42 production and their use in treating alzheimer's disease (AD)

Compositions for reducing aβ 42 production and their use in treating alzheimer's disease (AD)

US Patent 8846721 · Granted Sep 30, 2014

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunotherapeutic composition for prevention of obesity, nonalcoholic fatty live2025
Hyperimmunized egg product for treatment or prevention of coronavirus infection2025
Hyperimmunized egg product for treatment or prevention of coronavirus infection2023
Compositions for reducing Aβ 42 production and their use in treating alzheimer's2016
Compositions for reducing Aβ 42 production and their use in treating alzheimer's2016
Compositions for reducing Aβ 42 production and their use in treating alzheimer's2016
Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) producti2013
5(S)-(2′-hydroxyethoxy)-20(S)-camptothecin and its preparation and use for the t2011
Methods for the treatment of diabetes-associated dyslipdemia2011
Crystalline form of 5(S)-(2-hydroxyethoxy)-20(S)-camptothecin2009
5(S)-(2′-hydroxyethoxy)-20(S)-camptothecin and its preparation and use for the t2009
Medical devices employing triazine compounds and compositions thereof2008